Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 06, 2019

SELL
$15.25 - $22.4 $461,678 - $678,137
-30,274 Closed
0 $0
Q3 2018

Oct 16, 2018

SELL
$6.45 - $21.6 $338,476 - $1.13 Million
-52,477 Reduced 63.42%
30,274 $586,000
Q2 2018

Jul 17, 2018

BUY
$2.95 - $7.45 $244,115 - $616,494
82,751 New
82,751 $604,000

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $188M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.